Memphis Pharmaceuticals & Chemical Industries (EGX: MPCI)

MPCI Revenue

Memphis Pharmaceuticals & Chemical Industries had revenue of 399.66M EGP in the quarter ending September 30, 2024, with 118.81% growth. This brings the company's revenue in the last twelve months to 1.09B, up 56.42% year-over-year. In the fiscal year ending June 30, 2024, Memphis Pharmaceuticals & Chemical Industries had annual revenue of 871.91M with 31.34% growth.

• Revenue (ttm): 1.09B
• Revenue Growth: +56.42%
• P/S Ratio: n/a
• Revenue / Employee: 7.56M
• Employees: 144
• Market Cap: 324.06M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	871.91M	208.07M	31.34%
Jun 30, 2023	663.83M	112.57M	20.42%
Jun 30, 2022	551.26M	33.15M	6.40%
Jun 30, 2021	518.11M	29.70M	6.08%
Jun 30, 2020	488.41M	125.34M	34.52%